MX2009003533A - Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico. - Google Patents

Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico.

Info

Publication number
MX2009003533A
MX2009003533A MX2009003533A MX2009003533A MX2009003533A MX 2009003533 A MX2009003533 A MX 2009003533A MX 2009003533 A MX2009003533 A MX 2009003533A MX 2009003533 A MX2009003533 A MX 2009003533A MX 2009003533 A MX2009003533 A MX 2009003533A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
antifungal agent
combination
phenylamidine derivative
type antifungal
Prior art date
Application number
MX2009003533A
Other languages
English (en)
Inventor
Nishikawa Hiroshi
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of MX2009003533A publication Critical patent/MX2009003533A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición farmacéutica que comprende un derivado de fenilamidina o una sal, del mismo, representado por una formula general, en donde R1 y R2 pueden ser iguales o diferentes, y representa un grupo alquilo con 3 a 4 átomos de carbono opcionalmente sustituido; y uno o más agentes seleccionados de agentes antifúngicos de azol, agentes antifúngicos de polieno, agentes antifúngicos de candino, agentes antifúngicos de fluoropirimidina y un método para uso en combinación del derivado de fenilamidina o una sal, del mismo y los agentes son útiles para tratar infecciones fúngicas ocasionadas por un patógeno micótico.
MX2009003533A 2006-10-06 2007-10-03 Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico. MX2009003533A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006274709 2006-10-06
PCT/JP2007/069341 WO2008044562A1 (fr) 2006-10-06 2007-10-03 Composition pharmaceutique contenant un dérivé de phénylamidine et procédé d'utilisation de la composition pharmaceutique combinée à un agent antifongique

Publications (1)

Publication Number Publication Date
MX2009003533A true MX2009003533A (es) 2009-07-17

Family

ID=39282771

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003533A MX2009003533A (es) 2006-10-06 2007-10-03 Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico.

Country Status (21)

Country Link
US (1) US8173157B2 (es)
EP (1) EP2070536B1 (es)
JP (1) JP5132569B2 (es)
KR (1) KR101409258B1 (es)
CN (1) CN101522195B (es)
AT (1) ATE538789T1 (es)
AU (1) AU2007305626B2 (es)
BR (1) BRPI0719157A2 (es)
CA (1) CA2664915C (es)
CY (1) CY1112617T1 (es)
DK (1) DK2070536T3 (es)
ES (1) ES2376130T3 (es)
MX (1) MX2009003533A (es)
NO (1) NO20091101L (es)
NZ (1) NZ575714A (es)
PL (1) PL2070536T3 (es)
PT (1) PT2070536E (es)
RU (1) RU2429843C2 (es)
SI (1) SI2070536T1 (es)
WO (1) WO2008044562A1 (es)
ZA (1) ZA200902053B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
TWI395735B (zh) * 2007-07-04 2013-05-11 Toyama Chemical Co Ltd ４－｛３－〔４－（３－｛４－〔胺基（丁氧基羰基亞胺基）甲基〕苯氧基｝丙基）－１－哌啶基〕丙氧基｝－ｎ’－（丁氧基羰基）苄脒之新穎結晶
JPWO2012060448A1 (ja) 2010-11-05 2014-05-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
KR102044734B1 (ko) * 2012-04-20 2019-11-15 에자이 알앤드디 매니지먼트 가부시키가이샤 캡슐 제형
AU2017348305B2 (en) 2016-10-31 2022-04-21 Biocryst Pharmaceuticals, Inc. Prodrugs of kallikrein inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JPH03288051A (ja) 1990-03-30 1991-12-18 Mazda Motor Corp カムシャフトおよびその製造方法
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
CZ88499A3 (cs) * 1996-09-12 1999-10-13 Merck And Co., Inc. Kombinace látek s antifungálním účinkem
AUPQ066399A0 (en) 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
IL163798A0 (en) 2002-03-06 2005-12-18 Toyama Chemical Co Ltd Novel arylamidine derivative or salt thereof
JP4937506B2 (ja) * 2003-09-05 2012-05-23 富山化学工業株式会社 新規なアリールアミジン誘導体またはその塩
JP2007504460A (ja) * 2003-09-05 2007-03-01 メルク　エンド　カムパニー　インコーポレーテッド 固定相及び該固定相を用いた精製プロセス
JP4885722B2 (ja) 2004-06-30 2012-02-29 富山化学工業株式会社 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤
CN1596897A (zh) * 2004-07-26 2005-03-23 范敏华 一种伊曲康唑注射剂及其制备方法
WO2006011499A1 (ja) * 2004-07-28 2006-02-02 Toyama Chemical Co., Ltd. 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤
EP1867332B1 (en) 2005-04-07 2011-08-24 Toyama Chemical Co., Ltd. Pharmaceutical composition and method using antifungal agent in combination
JP5314284B2 (ja) 2005-11-09 2013-10-16 富山化学工業株式会社 ４−（３−（４−（３−（４−シアノフェノキシ）プロピル）−１−ピペリジニル）プロポキシ）ベンゾニトリルの製造法およびその中間体
US8536343B2 (en) * 2005-12-29 2013-09-17 Toyama Chemical Co., Ltd. Arylamidine derivative, salt thereof and antifungal agent containing those

Also Published As

Publication number Publication date
EP2070536B1 (en) 2011-12-28
NO20091101L (no) 2009-04-27
WO2008044562A1 (fr) 2008-04-17
DK2070536T3 (da) 2012-04-10
US8173157B2 (en) 2012-05-08
BRPI0719157A2 (pt) 2014-02-04
EP2070536A4 (en) 2010-02-10
CY1112617T1 (el) 2016-02-10
ES2376130T3 (es) 2012-03-09
RU2429843C2 (ru) 2011-09-27
NZ575714A (en) 2011-05-27
JP5132569B2 (ja) 2013-01-30
KR20090069317A (ko) 2009-06-30
PL2070536T3 (pl) 2012-06-29
PT2070536E (pt) 2012-03-06
JPWO2008044562A1 (ja) 2010-02-12
AU2007305626A1 (en) 2008-04-17
US20100098750A1 (en) 2010-04-22
CN101522195A (zh) 2009-09-02
CN101522195B (zh) 2012-01-18
KR101409258B1 (ko) 2014-06-18
EP2070536A1 (en) 2009-06-17
AU2007305626B2 (en) 2013-01-10
CA2664915A1 (en) 2008-04-17
SI2070536T1 (sl) 2012-03-30
RU2009117207A (ru) 2010-11-20
CA2664915C (en) 2014-01-07
ATE538789T1 (de) 2012-01-15
ZA200902053B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
MY148424A (en) Fungicidal azocyclic amides
WO2010065579A3 (en) Fungicidal heterocyclic compounds
TW200612947A (en) Organic compounds
WO2008019395A3 (en) Compounds for improving learning and memory
WO2008091580A3 (en) Fungicidal amides
EP2402332A3 (en) Fungicidal heterocyclic compounds
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
TW200611898A (en) Organic compounds
MX2009005934A (es) Compuestos organicos.
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
EP2532236A3 (en) Substituted benzene fungicides
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
MX2009005048A (es) Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.
ATE554085T1 (de) Neue inhibitoren von glutaminylcyclase
TW200608978A (en) Organic compounds
IL178771A0 (en) 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2008048589A3 (en) Compounds and methods for treatment of hcv
MX2009003533A (es) Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico.
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
UA101018C2 (ru) Пирролопиримидинкарбоксамиды
EA200701852A1 (ru) Производные аминокислот
UA105639C2 (uk) Протигрибковий засіб
MX2010010876A (es) Piperidinas sustituidas como compuestos terapeuticos.

Legal Events

Date Code Title Description
FG Grant or registration